•  
  •  
  •  
  •  

2025-11-29 03:58:49

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Veefin Wins Supply Chain Finance Mandate from Bank of the Philippine Islands for Philippines Deployment
  • Arvind SmartSpaces adds a new premium residential high-rise project in Ahmedabad with a top-line potential of ~Rs. 400 crore
  • MAHAGENCO and NTPC consortium's resolution plan for Sinnar Thermal Power Ltd approved by NCLT
  • Patel Engineering Ltd fixes Dec 4, 2025 as record date for 7:40 rights issue
  • Ramky Infrastructure Ltd wins award ET INFRA LEADERSHIP Awards 2025

Keywords Selected:  CaplinPointLaboratories

Stock Report

  • Caplin Point Laboratories Ltd's arm acquires land in Mexico
  • Caplin Point Laboratories Ltd consolidated Q2FY26 PAT up at Rs. 154.45 crores
  • Caplin Steriles Ltd receives USFDA approval for ANDA Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection
  • Caplin Steriles Ltd granted final approval for ANDA Milrinone Lactate in 5% Dextrose Injection by USFDA
  • Caplin Point Laboratories Ltd Q1 FY2026 consolidated net profit up at Rs. 152.80 crores
  • Caplin Point Laboratories Limited declares interim dividend of Rs. 3
  • Caplin Point Laboratories Ltd Q4 FY2025 consolidated PAT climbs to Rs. 142.57 crores
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Haloperidol Decanoate Injection
  • Caplin Steriles Ltd gets USFDA approval for Phytonadione Injectable Emulsion
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
  • Caplin Steriles gets USFDA approval for Levetiracetam in Sodium Chloride Injection, Infusion Bags
  • Caplin Steriles gets USFDA approval for Difluprednate Ophthalmic Emulsion
  • Caplin Point Laboratories Ltd's consolidated net profit for Q2FY25 higher at Rs. 130.80 crores
  • ANVISA - Brazil completes inspection at Caplin Steriles' facility at Gummidipoondi
  • Caplin Steriles Ltd gets USFDA approval for Ephedrine Sulfate injection USP
  • Caplin Point gets Colombia approval for Softgel Capsules
  • Caplin Steriles gets USFDA approval for Ofloxacin Ophthalmic Solution
  • Caplin Steriles gets USFDA approval for Ketorolac Tromethamine Ophthalmic Solution
  • Caplin Group successfully completes new Oncology facility, commences operations
  • Caplin Group announces Strategic Investment of INR 700 Crores in Tamil Nadu
  • Caplin Steriles Ltd gets USFDA approval for Ofloxacin OTIC Solution
  • Caplin Steriles gets USFDA approval for Norepinephrine Bitartrate Injection
  • Caplin Steriles receives EIR from US FDA
  • Caplin Point listed on Forbes Asia's '200 Best Under a Billion' for 2023

Latest Post

  • Veefin Wins Supply Chain Finance Mandate from Bank of the Philippine Islands for Philippines Deployment
  • Arvind SmartSpaces adds a new premium residential high-rise project in Ahmedabad with a top-line potential of ~Rs. 400 crore
  • MAHAGENCO and NTPC consortium's resolution plan for Sinnar Thermal Power Ltd approved by NCLT
  • Patel Engineering Ltd fixes Dec 4, 2025 as record date for 7:40 rights issue
  • Ramky Infrastructure Ltd wins award ET INFRA LEADERSHIP Awards 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024